Alosh Madala, MD
Urology · Kansas City, MONPI 1285894030
Payments from drug & device makers
Across 111 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$312
- UCB, Inc.$282
- Acadia Pharmaceuticals Inc$213
- Astellas Pharma US Inc$167
- Davol Inc.$148
- EMD Serono, Inc.$138
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,40897%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 4 | $312 |
| UCB, Inc. | 14 | $282 |
| Acadia Pharmaceuticals Inc | 15 | $213 |
| Astellas Pharma US Inc | 7 | $167 |
| Davol Inc. | 1 | $148 |
| EMD Serono, Inc. | 8 | $138 |
| Profound Medical Corp. | 1 | $104 |
| Pfizer | 4 | $100 |
| Kyowa Kirin, Inc. | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 6 | $88 |
| Biogen | 4 | $73 |
| Coloplast | 5 | $66 |
| AbbVie(2 entities) | 3 | $47 |
| Rochester Medical Corporation | 2 | $46 |
| Convatec Inc. | 2 | $39 |
| Olympus America Inc. | 2 | $39 |
| Urogen Pharma, Inc. | 1 | $38 |
| Urovant Sciences Inc | 2 | $34 |
| Boston Scientific | 2 | $34 |
| Novartis | 1 | $32 |
| Antares Pharma, Inc. | 2 | $30 |
| Corium, LLC | 1 | $28 |
| Medtronic(2 entities) | 2 | $28 |
| 180 Medical, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 2 | $27 |
| Agiliti Surgical, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Grifols USA, LLC | 1 | $23 |
| Intuitive Surgical | 1 | $20 |
| Kerecis Limited | 1 | $15 |
| Telix Pharmaceuticals | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Laborie Medical Technologies Corp. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Myovant Sciences Inc. | 1 | $12 |
| Teleflex LLC | 1 | $12 |
| Amgen | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTA AH FLEXITIP$148
- AQUABEAM SYSTEM$125
- Tulsa-Pro$104
How this compares
$2,473 in reported general payments places this provider in the 40th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 53 | $34,575 |
| Tamsulosin Hcl | 224 | $3,596 |
| Oxybutynin Chloride ErOxybutynin Chloride | 144 | $3,155 |
| Silodosin | 14 | $1,199 |
| Solifenacin Succinate | 15 | $826 |
| Finasteride | 61 | $695 |
| Ciprofloxacin Hcl | 28 | $304 |
| NitrofurantoinNitrofurantoin Macrocrystal | 12 | $285 |
| Oxybutynin Chloride | 12 | $125 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $167 | $34,57553 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 250 urology providers in Missouri.
Other urology in Kansas City
- Samuel KuykendallKansas City$141K
- Donald NeffKansas City$141K
- Lukas HockmanKansas City$14K
- Patrick ProbstKansas City$14K
- Daniel HolmesKansas City$9K
- Travis BullockSaint Louis$751K
- Michael JohnsonSaint Louis$471K
- Gregory AuffenbergSaint Louis$468K
- Gerald AndrioleSaint Louis$308K
- Hing LaiSaint Louis$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.